lauroylcarnitine has been researched along with vasoactive intestinal peptide in 1 studies
| Studies (lauroylcarnitine) | Trials (lauroylcarnitine) | Recent Studies (post-2010) (lauroylcarnitine) | Studies (vasoactive intestinal peptide) | Trials (vasoactive intestinal peptide) | Recent Studies (post-2010) (vasoactive intestinal peptide) |
|---|---|---|---|---|---|
| 11 | 0 | 6 | 10,873 | 123 | 1,221 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Couet, W; Dufes, C; Gaillard, A; Gaillard, F; Muller, JM; Olivier, JC | 1 |
1 other study(ies) available for lauroylcarnitine and vasoactive intestinal peptide
| Article | Year |
|---|---|
Brain delivery of vasoactive intestinal peptide (VIP) following nasal administration to rats.
Topics: Administration, Intranasal; Animals; Autoradiography; Brain; Carnitine; Chickens; Chromatography, High Pressure Liquid; Drug Stability; Hydrogen-Ion Concentration; In Vitro Techniques; Injections, Intravenous; Iodine Radioisotopes; Laurates; Male; Nasal Lavage Fluid; Osmolar Concentration; Permeability; Pharmaceutic Aids; Radioligand Assay; Rats; Rats, Sprague-Dawley; Tissue Distribution; Tissue Extracts; Vasoactive Intestinal Peptide | 2003 |